APEX1 and neoplasm: In the neoadjuvant-group TMAs, 16 out of 46 tumours that were stained for APE1 showed specific nuclear staining (34.8%) (Figure 1B) and 32 out of 46 (69.6%) were positive in the cytoplasm.